A not-for-profit organization founded to support basic and clinical research programs related to the treatment and prevention of cancer at the University of Chicago Medicine Comprehensive Cancer Center; to enhance cancer care, develop more effective and safer therapies, and promote prevention and screening research through fundraising.
The University of Chicago Cancer Research Foundation centers its giving on cancer research at the University of Chicago Medicine Comprehensive Cancer Center, with a clear emphasis on prevention, screening, and the development of safer, more effective therapies. Its recent grant history shows a concentrated institutional pattern: $2,539,475 in 2024 and $1,360,261 in 2023, both to the University of Chicago in Chicago for cancer research. That pairing aligns with the foundation’s stated purpose of supporting basic and clinical research programs tied to treatment and prevention. The foundation also uses its grantmaking to strengthen research capacity within the cancer center, including support for junior faculty and early-career scientists. Beyond core research funding, its program descriptions point to clinical trials, patient care improvement, and supportive oncology as part of the institutional ecosystem it helps sustain. The annual Simon M. Shubitz Cancer Prize and Lectureship adds a recognition component by bringing an internationally respected scientist to the University of Chicago, linking research support with scientific exchange and visibility.
Cancer research is the foundation’s main giving area, and the largest recent grant went to the University of Chicago for CANCER RESEARCH. That support sits alongside a broader institutional mission to advance basic and clinical research programs at the Comprehensive Cancer Center. A separate program, Auxiliary Board Sponsored Research / Junior Faculty Support, is designed to fund young scientists and junior faculty in the early stages of their careers. The foundation also names cancer prevention and screening research as a priority, showing that its support extends beyond treatment-focused work. In addition, its stated taxonomy includes clinical/translational oncology, clinical trials, patient care improvement, and supportive oncology, indicating a research portfolio that connects laboratory work with patient-facing cancer care.
Grant size is large and tightly clustered: the p25 is $1,655,064, the median is $1,949,868, and the p75 is $2,244,672. The recent record also shows a recurring recipient pattern, with the University of Chicago receiving grants in both 2023 and 2024. The foundation is an institutional supporter rather than an individual-giving funder, and it does not make program-related investments. One active program, Auxiliary Board Sponsored Research / Junior Faculty Support, accepts unsolicited requests and is directed toward research support for junior faculty and young scientists.
$444K
$6.1M
$812K
$484K
Most grants fall between $1.7M and $2.2M, with a median of $1.9M.
25th Percentile
$1.7M
Median
$1.9M
75th Percentile
$2.2M
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Giving is local and entirely concentrated in Illinois. All reported grants went to recipients in the HQ state, and the recent grants list names Chicago, IL as the recipient location for both awards to the University of Chicago. The country distribution is also fully domestic: 2 grants, or 100%, went to U.S. recipients. Program descriptions reinforce this local pattern by tying active support to Chicago and the University of Chicago.
It supports basic and clinical research programs related to cancer treatment and prevention at the University of Chicago Medicine Comprehensive Cancer Center. Its stated priorities include cancer research, prevention, screening, clinical trials, and support for safer, more effective therapies.
Yes. Its Auxiliary Board Sponsored Research / Junior Faculty Support program is described as having a primary focus on funding young scientists and junior faculty in the early stages of their careers.
The grant-size distribution is very high and relatively tight: p25 is $1,655,064, median grant size is $1,949,868, and p75 is $2,244,672. The recent grants shown also fall in the multi-million-dollar range.
Its giving is local. All reported grants went to recipients in Illinois, and the recent grants list shows both awards going to the University of Chicago in Chicago, IL.
Yes, for the Auxiliary Board Sponsored Research / Junior Faculty Support program. That program is marked as accepting unsolicited requests and is aimed at research support for junior faculty and young scientists.
2026
Source: IRS Form 990-PF, fiscal year 2026.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| UNIVERSITY OF CHICAGO | CHICAGO, IL | $444,480 | 2026 | CANCER RESEARCH |
| UNIVERSITY OF CHICAGO | CHICAGO, IL | $2,060,752 | 2025 | CANCER RESEARCH |
| University of Chicago | Chicago, IL | $2,539,475 | 2024 | CANCER RESEARCH |
| UNIVERSITY OF CHICAGO | Chicago, IL | $1,360,261 | 2023 | Cancer Research |